Dalotuzumab (Synonyms: MK-0646; h7C10) |
رقم الكتالوجGC26322 |
Dalotuzumab (MK-0646) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab works by inhibiting IGF-1 and IGF-2 mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1005389-60-5
Sample solution is provided at 25 µL, 10mM.
Dalotuzumab (MK-0646) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab works by inhibiting IGF-1 and IGF-2 mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation. Dalotuzumab can also induce cell apoptosis and cycle arrest. Dalotuzumab can enhance its in vitro and in vivo anti-tumor activity when used in combination with other anticancer active molecules, such as statin like molecules.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *